Directorio

We are doing this study to learn more about how different factors affect people with two types of dry eye conditions: Sjögren's dry eye (SjD) and non-Sjögren's dry eye. Specifically, we want to know how neurotrophic keratitis (a condition where the cornea loses sensation) versus the severity of tear film and eye surface issues impact the structure and function of the cornea (the clear front part of the eye). We also want to find out if having dry eyes leads to less feeling in the cornea, and if this reduced feeling is linked to eye pain or pain in other parts of the body.

We are doing this study to compare the outcomes of people who get their after-transplant care in the hospital versus in their home. This study is important to learn if getting after-transplant care in a patient's home can lead to better outcomes.

We are doing this study learn more about how we can identify potential biomarkers in your eyes that may let us predict and/or diagnose one or more illnesses or medical conditions. Although we will not be able to make these diagnoses now, one day in the future we may be able to use the information we have learned now to make these diagnoses in other people:

• Alzheimer's disease
• Mild cognitive impairment
• Parkinson's disease
• Frontotemporal dementia
• Dementia of Lewy body
• Multiple sclerosis
• Traumatic Brain Injury
• PTSD
• ALS
• Huntington's
• Down syndrome

We are doing this study to collect blood donations from those who have HIV to make sure laboratories across the United States and other countries are testing their blood to know and help support the course of HIV and other infectious diseases of the immune system as well as look at possible vaccines.

We are doing this study to develop and test a nurse-delivered program for women who are experiencing premature and early menopause after cancer. The study's program includes personalized menopause health education and skills training to help manage menopause symptoms.

We are doing this study to find out if an experimental drug called IMVT-1402 (the study drug) can help control cutaneous lupus erythematosus (CLE). We want to know how well the study drug works in comparison to a placebo (inactive substance that has no drug in it).

We are doing this study to compare 2 different approaches for patients who have surgery to remove non-small cell lung cancer (NSCLC). We want to see if giving patients an immunotherapy drug called durvalumab (the study drug) after surgery has different outcomes than the usual approach, which is to closely monitor a patient's condition for any changes.

We are doing this study to find out if images taken of the eye using a special type of camera placed inside a surgical microscope, called Microscope Integrated Optical Coherence Tomography (MIOCT), will give us new information during surgery that will improve both how we perform eye surgery and the results of surgery.